HRAS Q61R [plasma membrane]

Stable Identifier
R-HSA-6802458
Type
Protein [EntityWithAccessionedSequence]
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
External Reference Information
External Reference
Gene Names
HRAS, HRAS1
Chain
chain:1-186, initiator methionine:, chain:2-186, propeptide:187-189
Other Identifiers
11733320_a_at
11744709_a_at
1590_s_at
16733952
212983_PM_at
212983_at
3265
3358091
3358092
3358093
3358094
3358095
3358096
3358097
3358098
3358099
3358100
3358101
3358102
3358103
3358105
3358106
3358107
3358108
3358109
3358111
35701_at
7945436
A_23_P98183
GE57461
GO:0000139
GO:0000165
GO:0000166
GO:0001934
GO:0002376
GO:0003824
GO:0003924
GO:0003925
GO:0005515
GO:0005525
GO:0005634
GO:0005654
GO:0005737
GO:0005789
GO:0005794
GO:0005829
GO:0005886
GO:0006355
GO:0006357
GO:0006897
GO:0006935
GO:0007165
GO:0007166
GO:0007264
GO:0007265
GO:0008284
GO:0008285
GO:0008286
GO:0009887
GO:0010628
GO:0010629
GO:0012501
GO:0014044
GO:0016020
GO:0016192
GO:0016787
GO:0019003
GO:0030335
GO:0032729
GO:0032956
GO:0034260
GO:0042088
GO:0042127
GO:0042552
GO:0042832
GO:0043226
GO:0043406
GO:0043410
GO:0043495
GO:0043524
GO:0043547
GO:0045944
GO:0046330
GO:0048144
GO:0048146
GO:0048169
GO:0048471
GO:0048856
GO:0050679
GO:0050852
GO:0051402
GO:0051726
GO:0060090
GO:0060612
GO:0070374
GO:0071480
GO:0090303
GO:0090314
GO:0090398
GO:0090402
GO:0097193
GO:0098542
GO:0098696
GO:0098772
GO:0098978
GO:0160185
GO:1900029
GO:1905360
GO:2000630
HMNXSV003016066
Hs.37003.0.S1_3p_at
Hs.37003.0.S1_3p_x_at
ILMN_1699798
ILMN_1773751
J00277_at
PH_hs_0031161
TC11001236.hg
V00574_s_at
Participates
Other forms of this molecule
Modified Residues
Name
L-glutamine 61 replaced with L-arginine
Coordinate
61
PsiMod
A protein modification that effectively removes or replaces an L-glutamine.
A protein modification that effectively converts a source amino acid residue to an L-arginine.
Disease
Name Identifier Synonyms
bladder carcinoma DOID:4007 carcinoma of urinary bladder, carcinoma bladder, carcinoma OF BLADDER, carcinoma of bladder (disorder), carcinoma bladder
melanoma DOID:1909 Naevocarcinoma, melanoma, melanoma, malignant melanoma, morphology (morphologic abnormality), malignant melanoma NOS (morphologic abnormality), malignant melanoma (disorder), malignant melanoma, malignant melanoma, malignant melanoma, malignant melanoma
thyroid cancer DOID:1781 Thyroid gland neoplasm, thyroid cancer, thyroid neoplasm, neoplasm of thyroid gland, thyroid neoplasm, Thyroid neoplasm, malignant tumour of thyroid gland, malignant neoplasm of thyroid gland
Cross References
Guide to Pharmacology - Targets
OpenTargets
ZINC - Substances
ZINC target
PRO
GlyGen
ZINC - Investigational
COSMIC
IntEnz
Pharos - Targets
Orphanet
ZINC - Predictions - Purchasable
HMDB Protein
Interactors (32)
Accession #Entities Entities Confidence Score Evidence (IntAct)
 UniProt:P04049 RAF1  20 0.978 30
 UniProt:Q07889 SOS1  3 0.938 11
 UniProt:P15056 BRAF  20 0.904 8
 UniProt:Q9NZL6 RGL1  1 0.744 4
 UniProt:Q12967 RALGDS  1 0.683 3
 UniProt:Q8WUX9 CHMP7  2 0.659 4
 UniProt:P21359 NF1  20 0.604 3
 UniProt:P42337 Pik3ca  1 0.589 3
 UniProt:Q9Y5Z9 UBIAD1  1 0.581 9
 UniProt:P12931 SRC  6 0.571 2
 UniProt:P11233 RALA  2 0.571 2
 UniProt:Q96EZ8 MCRS1  1 0.556 3
 UniProt:P22415 USF1  2 0.556 3
 UniProt:P10809 HSPD1  6 0.556 3
 UniProt:Q99558 MAP3K14  5 0.556 3
 UniProt:Q9EQZ6  1 0.556 3
 UniProt:Q00994 BEX3  1 0.556 3
 UniProt:Q13573 SNW1  1 0.556 3
 UniProt:P24941 CDK2  5 0.556 3
 UniProt:Q8N5V2 NGEF  2 0.556 3
 UniProt:O95674 CDS2  1 0.556 3
 UniProt:O15534 PER1  4 0.556 3
 UniProt:Q9BXU0 TEX12  1 0.556 3
 UniProt:O75528 TADA3  1 0.556 3
 UniProt:Q13352 ITGB3BP  2 0.556 3
 UniProt:A0AVK6 E2F8  1 0.556 3
 UniProt:O14641 DVL2  5 0.556 3
 UniProt:P53611 RABGGTB  2 0.527 3
 UniProt:Q7Z569 BRAP  2 0.524 3
 UniProt:Q03135 CAV1  5 0.508 2
 UniProt:Q16850 CYP51A1  1 0.483 2
 UniProt:P42684 ABL2  1 0.462 2
Cite Us!